Kawate T, Michel JC, Birdsong WT, Gouaux E (2009) Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460:592–598. https://doi.org/10.1038/nature08198

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hattori M, Gouaux E (2012) Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485:207–212. https://doi.org/10.1038/nature11010

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abdulqawi R, Dockry R, Holt K, Layton G, McCarthy BG, Ford AP, Smith JA (2015) P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 385:1198–1205. https://doi.org/10.1016/S0140-6736(14)61255-1

Article  PubMed  CAS  Google Scholar 

Richards D, Gever JR, Ford AP, Fountain SJ (2019) Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation. Br J Pharmacol 176:2279–2291. https://doi.org/10.1111/bph.14677

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pijacka W, Moraes DJ, Ratcliffe LE, Nightingale AK, Hart EC, da Silva MP, Machado BH, McBryde FD, Abdala AP, Ford AP, Paton JF (2016) Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nat Med 22:1151–1159. https://doi.org/10.1038/nm.4173

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gonzalez-Montelongo M, Fountain SJ (2021) Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses. Vascul Pharmacol 136:106810. https://doi.org/10.1016/j.vph.2020.106810

Gonzalez-Montelongo M, Meades JL, Fortuny-Gomez A, Fountain SJ (2023) Neuropeptide Y: direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries. Vasc Pharmacol 151:107192. https://doi.org/10.1016/j.vph.2023.107192

Layhadi JA, Turner J, Crossman D, Fountain SJ (2018) ATP evokes Ca2+ responses and CXCL5 secretion via P2X4 receptor activation in human monocyte-derived macrophages. J Immunol 200:1159–1168. https://doi.org/10.4049/jimmunol.1700965

Article  PubMed  CAS  Google Scholar 

Layhadi JA, Fountain SJ (2019) ATP-evoked intracellular Ca2+ responses in M-CSF differentiated human monocyte-derived macrophage are mediated by P2X4 and P2Y11 receptor activation. Int J Mol Sci 20:5113. https://doi.org/10.3390/ijms20205113

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yoshida K, Ito M, Sato N, Obayashi K, Yamamoto K, Koizumi S, Tanaka S, Furuta K, Matsuoka I (2020) Extracellular ATP augments antigen-induced murine mast cell degranulation and allergic responses via P2X4 receptor activation. J Immunol 204:3077–3085. https://doi.org/10.4049/jimmunol.1900954

Article  PubMed  CAS  Google Scholar 

Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778–783. https://doi.org/10.1038/nature01786

Article  PubMed  CAS  Google Scholar 

Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, Buell GN, Reeve AJ, Chessell IP, Rassendren F (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28:11263–11268. https://doi.org/10.1523/JNEUROSCI.2308-08.2008

Article  PubMed  PubMed Central  CAS  Google Scholar 

Miklavc P, Frick M (2011) Vesicular calcium channels as regulators of the exocytotic post-fusion phase. Commun Integr Biol 4:796–798. https://doi.org/10.4161/cib.17935

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yamamoto K, Korenaga R, Kamiya A, Ando J (2000) Fluid shear stress activates Ca2+ influx into human endothelial cells via P2X4 purinoceptors. Circ Res 87:385–391. https://doi.org/10.1161/01.RES.87.5.385

Article  PubMed  CAS  Google Scholar 

Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato T, Sekine K, Kato S, Isshiki M, Fujita T, Kobayashi M, Kawamura K, Masuda H, Kamiya A, Ando J (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12:133–137. https://doi.org/10.1038/nm1338

Article  PubMed  CAS  Google Scholar 

Garcia-Guzman M, Soto F, Gomez-Hernandez JM, Lund PE, Stühmer W (1997) Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. Mol Pharmacol 51:109–118. https://doi.org/10.1124/mol.51.1.109

Article  PubMed  CAS  Google Scholar 

Jones CA, Chessell IP, Simon J, Barnard EA, Miller KJ, Michel AD, Humphrey PPA (2000) Functional characterization of the P2X4 receptor orthologues. Br J Pharmacol 129:388–394. https://doi.org/10.1038/sj.bjp.0703059

Article  PubMed  PubMed Central  CAS  Google Scholar 

North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563–580. https://doi.org/10.1146/annurev.pharmtox.40.1.563

Article  PubMed  CAS  Google Scholar 

Fischer R, Kalthof B, Gruetzman R, Woltering E, Stelte-Ludwig B, Wuttke M (2004) Benzofuro-1,4-diazepin-2-onederivatives. Patent CA2519987A1. PCT/EP2004/002580

Hernandez-Olmos V, Abdelrahman A, El-Tayeb A, Freudendahl D, Weinhausen S, Müller CE (2012) N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists. J Med Chem 55:9576–9588. https://doi.org/10.1021/jm300845v

Article  PubMed  CAS  Google Scholar 

Ase AR, Honson NS, Zaghdane H, Pfeifer TA, Seguela P (2015) Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels. Mol Pharmacol 87:606–616. https://doi.org/10.1124/mol.114.096222

Article  PubMed  CAS  Google Scholar 

Werner S, Mesch S, Hillig RC, ter Laak A, Klint J, Neagoe I, Laux-Biehlmann A, Dahllof H, Brauer N, Puetter V, Nubbemeyer R, Schulz S, Bairlein M, Zollner TM, Steinmeyer A (2019) Discovery and characterization of the potent and selective P2X4 inhibitor N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and structure-guided amelioration of its CYP3A4 induction profile. J Med Chem 62:11194–11217. https://doi.org/10.1021/acs.jmedchem.9b01304

Article  PubMed  CAS  Google Scholar 

Inoue K (2021) Nociceptive signaling of P2X receptors in chronic pain states. Purinergic Signal 17:41–47. https://doi.org/10.1007/s11302-020-09743-w

Article  PubMed  CAS  Google Scholar 

D’Antongiovanni V, Pellegrini C, Benvenuti L, Fornai M, di Salvo C, Natale G, Ryskalin L, Bertani L, Lucarini E, di Cesare ML, Ghelardini C, Nemeth ZH, Haskó G, Antonioli L (2022) Anti-inflammatory effects of novel P2X4 receptor antagonists, NC-2600 and NP-1815-PX, in a murine model of colitis. Inflammation 45:1829–1847. https://doi.org/10.1007/s10753-022-01663-8

Article  PubMed  CAS  Google Scholar 

Obara K, Inaba R, Kawakita M, Murata A, Yoshioka K, Tanaka Y (2022) Effects of NP-1815-PX, a P2X4 receptor antagonist, on contractions in guinea pig tracheal and bronchial smooth muscles. Biol Pharm Bull 45(8):1158–1165

Stokes L, Layhadi JA, Bibic L, Dhuna K, Fountain SJ (2017) P2X4 receptor function in the nervous system and current breakthroughs in pharmacology. Front Pharmacol 8:1–15. https://doi.org/10.3389/fphar.2017.00291

Article  CAS  Google Scholar 

Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, di Virgilio F (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178:489–514. https://doi.org/10.1111/bph.15299

Article  PubMed  CAS  Google Scholar 

Williams WA, Linley JE, Jones CA, Shibata Y, Snijder A, Button J, Hatcher JP, Huang L, Taddese B, Thornton P, Schofield DJ (2019) Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain. Pain 160:1989–2003. https://doi.org/10.1097/j.pain.0000000000001587

Article  PubMed  CAS  Google Scholar 

Bidula S, bin Nadzirin I, Cominetti M, Hickey H, Cullum SA, Searcey M, Schmid R, Fountain SJ (2022) Structural basis of the negative allosteric modulation of 5-BDBD at human P2X4 receptors. Mol Pharmacol 101:33–44. https://doi.org/10.1124/MOLPHARM.121.000402

Article  PubMed  CAS